Skip to main content

Table 3 Cell surface markers of DC+AK and TIL

From: Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report

  DC+AK TIL
CD3 99.2 98.9
CD8 38.2 97.3
CD4 68.2 7
HLA-DR 97.9 95.7
CD83 19.1 2